Abstract
Depression is a major public health problem with high incidence in the world population. However, the currently available antidepressants exhibit a latency of 2-4 weeks to induce an improvement in symptoms and around 45% of the patients do not respond to these drugs, which act by facilitating the monoaminergic neurotransmission . With the search of new targets for treatment of this disord…